Application of sPD1 protein and/or sPD1 gene as immunologic adjuvant

An immune adjuvant and protein technology, applied in the field of biomedicine, can solve the problems of limited selection of preventive and therapeutic vaccine X

Active Publication Date: 2019-04-05
SHENZHEN INST OF ADVANCED TECH CHINESE ACAD OF SCI
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] The purpose of the present invention is to overcome the above-mentioned deficiencies of the prior art, provide a kind of application of sPD1 protein and/or sPD1 gene as immune adjuvant, and corresponding recom

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of sPD1 protein and/or sPD1 gene as immunologic adjuvant
  • Application of sPD1 protein and/or sPD1 gene as immunologic adjuvant
  • Application of sPD1 protein and/or sPD1 gene as immunologic adjuvant

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0035] On the other hand, the present invention also provides a method for preparing a recombinant protein vaccine, comprising the step of transfecting host cells with the above-mentioned recombinant plasmid and expressing it. Specifically, after the recombinant plasmid was transfected into 293T cells, the expression was identified, and the specific operation method was as follows: according to the routine method of molecular cloning in the laboratory, the endotoxin-free pcDNA3.1(+)-sPD1-mE6E7 plasmid was transfected to a growth density of 80%. After culturing 293T cells with 10% FBS DEME medium at 5% CO2 and 37°C for 48 hours, separate and collect the cell culture supernatant and cells, use E6 monoclonal antibody, use Western Blot to analyze and identify the cells and cell culture The expression of sPD1-mE6E7 fusion protein in the supernatant, SDS-PAGE electrophoresis and Western Blot were performed according to the molecular cloning experiment guide, the concentration of the ...

Embodiment 1

[0051] The recombinant expression vectors pcDNA3.1(+)-mE6E7 and pcDNA3.1(+)-sPD1-mE6E7 were transfected into 293T cells and their expression was identified.

[0052] First, transfect the endotoxin-free pcDNA3.1(+)-mE6E7 or pcDNA3.1(+)-sPD1-mE6E7 recombinant plasmid into 293T cells with a growth density of 80% according to the conventional method of molecular cloning in the laboratory. %CO 2 1. After culturing in 10% FBS DEME medium for 48 hours at 37° C., the cell culture supernatant and cells were separated and collected. Then, utilize E6 monoclonal antibody (commercially purchased, the brand is Abcam), adopt Western Blot to analyze and identify the expression of mE6E7 protein and sPD1-mE6E7 fusion protein in the cell and cell culture supernatant, SDS-PAGE electrophoresis and Western Blot method reference molecule The cloning experiment guide is carried out, the concentration of the stacking gel is 5%, the concentration of the separation gel is 12%, the concentration gel is ...

Embodiment 2

[0055] To verify the effect of PD1 on the immune adjuvant of HPV E6E7 RNA vaccine.

[0056] Construct the pcDNA3.1(+)-sPD1-mE6E7 plasmid containing the sPD1 gene coding sequence and the pcDNA3.1(+)-mE6E7 plasmid not containing the sPD1 coding sequence according to the method described in the instructions, and transcribe the two plasmids into RNA in vitro The corresponding RNA vaccines were obtained, and the specific vaccination scheme for mice is shown in Table 1:

[0057] Table 1

[0058]

[0059] The above-mentioned HPVmE6E7RNA vaccine group and sPD1+mE6E7RNA vaccine group were immunized with four injections. First, the vaccine was injected intramuscularly, and then the NEPA GENE animal electroporation device was used for electroporation stimulation. At a voltage of 80V, the pulse was 6 times, and the time interval between each pulse was 25ms. , the pulse frequency is 2Hz, and the electroporation is stimulated by the animal electroporation device to improve the immune ef...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the field of biological medicine, and particularly relates to application of an sPD1 protein and/or an sPD1 gene as an immunologic adjuvant to preparation of a recombinant HPVvaccine. In application, the sPD1 protein contains an amino acid sequence shown as SEQ ID NO:3, or an amino acid sequence with the same function, wherein the amino acid sequence with the same function is obtained after deletion, insertion or replacement of the amino acid sequence shown as SEQ ID NO:3; and the sPD1 gene contains an amino acid sequence shown as SEQ ID NO:1, or an amino acid sequence with the same function, wherein the amino acid sequence with the same function is obtained after deletion, insertion or replacement of the amino acid sequence shown as SEQ ID NO:1. sPD1 serves as the immunologic adjuvant to enhance the ability to stimulate an organism to generate an antibody by the HPV vaccine and induce the organism to generate humoral immune response, stimulate lymphocytes tosecrete IFN-gamma, and stimulate the organism to generate cellular immune response.

Description

technical field [0001] The invention belongs to the field of biomedicine, and in particular relates to an application of sPD1 protein and / or sPD1 gene as an immune adjuvant. Background technique [0002] Immune adjuvants, referred to as adjuvants for short, are immune enhancers. When injected together with antigens or pre-injected into the body, they can enhance the body's immune response to antigens or change the type of immune response. Adjuvants mainly play the role of immune enhancement through the following mechanisms: 1) Delaying the degradation and elimination of antigens, increasing the half-life of antigens, and more effectively stimulating the immune system; 2) Stimulating the mononuclear-phagocyte system, enhancing its processing and antigen presentation. 3) Stimulate the proliferation and differentiation of lymphocytes, increase the antibody titer of the body's primary and secondary immune responses; 4) Change the type of antibody production and produce delayed a...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K39/39A61K39/12A61P31/20A61P35/00C12N15/85C12N15/62
CPCA61K39/12A61K39/39C12N15/85C07K14/005C07K14/70521A61K2039/55516A61K2039/55511A61K2039/53A61K2039/575C07K2319/00C12N2710/20034C12N2710/20022
Inventor 王蒲邹晓华赵琦
Owner SHENZHEN INST OF ADVANCED TECH CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap